Table 1.
Summary of the clinicopathological features of hepatocellular carcinomas (n = 285).
| Parameters | Frequency (%) or Median (Range) |
|---|---|
| Sex, n (%) | |
| Male | 216 (75.8) |
| Female | 69 (24.2) |
| Age at operation, median (range, years) | 63 (29–87) |
| Etiology, n (%) | |
| Hepatitis B virus (HBV) | 202 (70.9) |
| Hepatitis C virus (HCV) | 25 (8.8) |
| HBV + HCV | 1 (0.3) |
| Alcohol | 14 (4.9) |
| Non-alcoholic fatty liver disease | 12 (4.2) |
| Uncertain etiology | 31 (10.9) |
| Tumor size, median (range, cm) | 3.2 (0.9–17) |
| Multiplicity present, n (%) | 49 (17.2) |
| Edmondson–Steiner grade, n (%) | |
| Grade I | 3 (1.0) |
| Grade II | 77 (27.0) |
| Grade III | 171 (60.0) |
| Grade IV | 34 (12.0) |
| Microvascular invasion present, n (%) | 113 (39.6) |
| Portal vein invasion present, n (%) | 19 (6.7) |
| Pathologic T category (AJCC 8th edition), n (%) | |
| pT1a | 37 (13.0) |
| pT1b | 101 (35.4) |
| pT2 | 112 (39.3) |
| pT3 | 11 (3.9) |
| pT4 | 24 (8.4) |
| Extrahepatic metastasis present, n (%) | 55 (19.3) |
| Cirrhosis in background liver present, n (%) | 152 (533.3) |
| Recurrence on follow-up present, n (%) | 161 (56.5) |
| Status at last follow-up, n (%) | |
| Alive | 128 (44.9) |
| Deceased of disease | 44 (15.4) |
| Deceased of other cause | 10 (3.5) |
| Follow up loss | 103 (36.2) |
| Overall survival, median (range, months) | 66.5 (0–163) |
| Disease-free survival, median (range, months) | 32.5 (0–163) |
AJCC, American Joint Committee on Cancer.